Drugs and xenobiotics bind to plasma proteins with varying degrees of affinity and the amount of binding has a direct effect on free drug concentration and subsequent pharmacokinetics. Multiple active and facilitative transport systems regulate the excretion of anionic compounds from the blood in excretory and barrier tissues.
Introduction
The proximal tubule is the primary site for renal secretory elimination of drugs, toxins, and their metabolites from the body. In addition, the proximal tubule exhibits a very high metabolic demand, since it mediates not only secretion of drugs and xenobiotics, but also the reabsorption of 60-80 % of the solute and water filtered by the glomerulus (Schnellmann, 2001) . Thus, the proximal tubule is particularly susceptible to injury by drugs and toxins.
Elimination of drugs, toxins and their metabolites is handled by several facilitative and active epithelial transport proteins expressed in the proximal tubule. Since the advent of cloning and the extensive study of these transporters in vitro, the impact of plasma protein has generally been overlooked when predicting physiological roles of transporters in the renal elimination of drugs. Nevertheless, plasma proteins are abundant and the potential for altered transporter efficacy is substantial. For example, serum albumin, a major transport/carrier plasma protein (4% w/v) makes up approximately 60% of total plasma protein (Peters, 1996; Gekle, 2005) . Indeed, it has long been known that to predict the efficacy of a drug in vivo, it is critical to account for plasma protein binding, as it will determine the availability of free drug, its half-life, and its subsequent renal elimination (Weiner et al., 1964) .
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5 Certainly, the impact of binding will vary depending upon the affinity of plasma proteins for the drug of interest. The organic anion, p-aminohippuric acid (PAH) provides an example of a substrate impacted minimally by plasma protein binding. It binds with low affinity to albumin (binding constant (K b ) ~ 2.3 x 10 3 M -1 ; Yoshimura et al., 1998) and its clearance (~700 ml/min), greatly exceeds the glomerular filtration rate (GFR; ~125 ml/min), indicating potent active renal tubular secretion (Schuster V.L., 1985) . In fact, at low doses plasma PAH is completely cleared in a single pass through the kidney. This property makes PAH clearance a measure of renal plasma flow, an important clinical indicator of renal function (Schuster V.L., 1985) .
At the other extreme is Ochratoxin A (OTA), a naturally occurring mycotoxin produced by several species of fungi (Van der Merwe et al., 1965a; Van der Merwe et al., 1965b) .
Albumin binds OTA with a K b of 5 x 10 6 M -1 , i.e. more than one thousand times greater than that of PAH (Il'ichev et al., 2002) , and leads to a renal clearance of only 0.11 ml/min, far lower than the GFR (Studer-Rohr et al., 2000) . Consistent with these measurements, the half-life of OTA in man is 35 days (Studer-Rohr et al., 2000) , and the fraction of free OTA in blood is less than 0.2% of the total (Hagelberg et al., 1989) .
Moreover, albumin-deficient mice show enhanced excretion of OTA, again indicating that albumin binding of OTA prolongs its systemic half-life in vivo (Kumagai, 1985) .
Nevertheless, data from in vivo studies (Stein et al., 1985) , in vitro assays examining both isolated renal tissue (Sokol et al., 1988; Bahnemann et al., 1997; Groves et al., 1998; Welborn et al., 1998) and cloned transporters (Cha et al., 2000) suggest that OTA may be transported by basolateral organic anion transporters. Indeed, in vitro expression studies
6 indicate that OTA is a high affinity substrate for the basolateral organic anion transporter (OAT) isoforms 1 and 3 (rOAT1 K m 2.1 uM; rOAT3, K m 0.7 uM) (Kusuhara et al., 1999; Tsuda et al., 1999) . Likewise, cloned organic anion transporters of both OAT and organic anion transporting polypeptide (OATP) families expressed in the apical membranes of the proximal tubule show significant affinity for OTA, with a K m of 23 µM for human OAT4 and of 17 µM for rat Oatp1 (Kontaxi et al., 1996; Babu et al., 2002) . However, these in vitro transport assays and expression studies were all conducted under albumin-free conditions. Thus, the contributions of these cloned transporters to the in vivo handling of OTA remain unclear. In this study we have systematically examined the ability of the cloned renal transporters to mediate OTA transport under conditions more closely approximating those seen in vivo, i.e., in the presence of human serum albumin. Two in vitro models were used, Xenopus laevis oocytes expressing hOAT1, hOAT3, hOAT4 and rOatp1, and a mammalian cell line stably expressing hOAT1. OTA transport under these conditions was compared with transport of two other organic anions that bind with lower affinity to albumin, estrone sulfate (ES; K b 1 X 10 5 M -1 ) and methotrexate (MTX, K b 2.8 X 10 3 M -1 ) (Zini, 1984; Pan et al., 1985) .
9 expressed on both the apical and basolateral membranes permitting cellular uptake to be studied in cells grown on solid support (Aslamkhan et al., 2003) . Cells were seeded (~ 1
x 10 5 cells/mL) on 8-well borosilicate slide chambers (Nalge Nunc International, Naperville, IL) or 24-well plates (Corning Glassworks, Corning, NY) and cultured for 2 days. Prior to treatment, medium was aspirated and cells were washed (x3) This article has not been copyedited and formatted. The final version may differ from this version. 
Results

Basolateral secretion
Organic anion transport
The effect of albumin on the uptake of OTA by the basolateral organic anion transporter, OAT1 was initially investigated using oocytes transfected with hOAT1. The data in Figure 1A (modified from (Dai et al., 2004) ) shows the uptake of 50 nM [ Although, the renal toxicant, OTA, is heavily bound to the plasma protein, albumin; > 99 % (Hagelberg et al., 1989) , it has nevertheless been shown to accumulate in the proximal segment of the nephron. The transport of OTA is thought due to secretion by OATs and reabsorption from the glomerular ultrafiltrate by non-ionic diffusion and by H + -dependent peptide and organic anion transporters (Gekle, 2005) . In a recent study investigating the contributions of rabbit OAT1 and 3 to the accumulation of OTA within the proximal tubule, it was stated that both transporters can mediate the cellular accumulation of OTA (Zhang et al., 2004) . However, when looking at these cloned organic anion transporters, the direct effect of plasma protein binding on substrate transport was not assessed, and to date has been poorly addressed in the literature.
In the present study, we examined the impact of albumin-substrate binding on uptake of OTA and other organic anions by individual organic anion transporters; particularly the OATs. In both the oocyte expression system and mammalian cell system, uptake of OTA This article has not been copyedited and formatted. The final version may differ from this version. (Figures 1 and 3) . In a MDCK cell line expressing hOAT1, intracellular OTA accumulation was observed by confocal microscopy. No accumulation was found when uptake was assayed in the presence of 1 % w/v HSA (Figure 2A ). Similarly uptake of If OTA accumulation in the kidney following chronic exposure to nanomolar concentrations is not due to secretion from blood via basolateral OATs, perhaps it can be explained by reabsorptive OTA accumulation from the ultrafiltrate. Following glomerular filtration of albumin bound-OTA, the proximal tubule as well as other segments of the nephron are known to reabsorb OTA. The mechanism of reabsorption has yet to be fully elucidated, although OTA has a high affinity for several apically expressed organic anion transporters, including hOAT4 and the organic anion transporting polypeptide transporter, rOatp1 (Kontaxi et al., 1996; Babu et al., 2002) .
Although albumin levels present in the tubular ultrafiltrate are much lower than in blood This article has not been copyedited and formatted. The final version may differ from this version. at the surface of the apical membrane (Gekle, 2005) . With environmental exposure to OTA, likely in the nanomolar range, albumin would still bind to the free OTA and reduce reabsorptive transport. In fact, in our initial investigations of nanomolar OTA uptake by OAT1, 0.005 % w/v albumin inhibited more than 98 % of OTA accumulation ( Figure   1A ). Investigation of apical transporters in the oocyte expression system (hOAT4; Figure 4 , rat Oatp1; Figure 5 ) showed increasing albumin concentrations effectively reduced uptake of 5 µM [ 3 H]-OTA, just as it prevented OTA uptake by hOAT1 and 3 (Figures 1-3) . OTA is so tightly bound to albumin (unless there is acute in vivo exposure to high concentrations) that the impact of organic anion transporters to proximal tubule accumulation, would be minimal at best.
To confirm these results were due to albumin binding and not limited to just OTA, we examined the renal transport of MTX and ES, OAT substrates that binds with a lower affinity to albumin (OTA>ES>MTX). Increasing albumin concentrations to near physiological levels in oocytes expressing hOAT1 had no significant effect on [ 3 H]-MTX accumulation ( Figure 6B ), yet accumulation of [ 3 H]-ES by hOAT3-expressing oocytes was significantly inhibited by albumin concentrations > 0.5 % w/v; Figure 6A . This correlates well with ES in vivo data which reports a low renal clearance (2.7 ml/min), indicative of no active secretion (Wright et al., 1978) . Also for MTX, our results confirm both the in vivo and in vitro data from the literature; renal clearance of MTX (~111 ml/min/m 2 ) exceeds GFR, indicating active secretion (Pauley et al., 2004) which has been linked to OAT mediated transport (Uwai et al., 2004) . Therefore, the degree of binding figure 6A ). These data are consistent with previous demonstration that binding constants determined at low albumin concentrations may overestimate the amount of bound drugs and drug metabolites actually observed at physiological concentrations (Weisiger et al., 2001) . Indeed, our in vitro transport data seems to reflect the free concentration of OTA (0.2 %) and ES (3 %) observed under physiological rather than theoretical conditions (Hagelberg et al., 1989; Tan et al., 2001) . In contrast, for the more weakly bound substrate MTX, the calculated free fraction under physiological conditions of 47 % (Zini, 1984) was reflected in our in vitro system (figure 6B).
For OTA, it would appear that unless the on/off rate of albumin binding is very high at the site of carrier mediated transport, or some mechanism exists to displace the substrate This article has not been copyedited and formatted. The final version may differ from this version. Nevertheless, chronic exposure to OTA does lead to accumulation and subsequent toxicity in the proximal tubule. In our study, we noted that there is still an albumin insensitive, albeit small component of OTA accumulation present in the hOAT1-expressing MDCK cells ( Figure 2C ). This is also present in both water-injected oocytes In the past, protein binding and its impact on the elimination of drugs and xenobiotics was routinely considered in analysis of the renal handling of drugs. Just over 30 years ago, Weiner drew attention to this issue, discussing the importance of protein binding in determining the route of renal elimination for organic anions (Weiner, 1973) . Around that time much attention was paid to the influence of substrate-plasma protein binding on renal clearance of organic anions (Ochwadt and Pitts, 1956; Block and Burrows, 1960;  This article has not been copyedited and formatted. The final version may differ from this version. However, since the advent of molecular analysis, and cloning of several OATs in the 1990s, this important factor has been generally overlooked and assumptions are made about in vivo substrate affinity and route of elimination based on data from plasma protein-free in vitro assays using cloned transporters. As illustrated by the data presented above for kidney, and complementary data on hepatic and intestinal transport by OATPs and multidrug resistance-associated protein (MRP) 2, caution must be exercised when extrapolating in vitro data to the in vivo situation (Jacquemin et al., 1994; Kanai et al., 1996; Berger et al., 2003; Cui and Walter, 2003) . Indeed, the data presented here argue strongly that renal substrate uptake is highly dependent upon not only transporter affinity, but also the free concentration of drug. Thus, even though the mechanism/s of OTA accumulation within the proximal tubule remain to be fully elucidated, the data presented 
